Caryn McDowell was Appointed as General Counsel at Revance-Therapeutics

Date of management change: May 08, 2018 

What Happened?

Newark, -based Revance-Therapeutics Appointed Caryn McDowell as General Counsel


About the Company

Revance Therapeutics is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, including muscle movement disorders and pain. The company`s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines, cervical dystonia and plantar fasciitis with the potential to be the first long-acting neuromodulator. Revance has developed a proprietary, stabilizing excipient peptide technology designed to create novel, differentiated therapies. The company has a comprehensive pipeline based upon its peptide technology, including injectable and topical formulations of daxibotulinumtoxinA.


About the Person

Caryn McDowell is General Counsel at Revance Therapeutics. Previously, she was GC at Cytokinetics. Previously, Caryn held various legal leadership positions in the industry


Info Source



Other IT executives who recently changed jobs as well: Miller Kendra, Dufour Nicolas, Walker Clint, Austin Jason, Zangrilli Diana, Fine Roger, Eaton Butler, Lynch Scott, Patterson Ellen, Formanis Adam, Hoban Jeffrey

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.